Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2000
12/21/2000WO2000044710A3 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
12/21/2000WO2000044391A3 Plasminogen kringle 4 region fragments and methods of use
12/21/2000WO2000040701A3 Non-myeloablative tolerogenic treatment
12/21/2000WO2000038660A3 Use of bisphosphonates for the prevention and treatment of infectious processes
12/21/2000WO2000036421A8 Use of vascular endothelial growth factor (vegf)
12/21/2000WO2000035950A3 Reagents and methods useful for detecting diseases of the breast
12/21/2000WO2000031094A3 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
12/21/2000WO2000020041A8 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent
12/21/2000WO2000007577A8 Phosphatidylcholine as a medicament for the protection of mucosa
12/21/2000DE19927574A1 Increasing content of flavonoids and phenols in plants, useful for e.g. preventing cardiovascular disease, by reducing activity of flavanone-3-hydroxylase
12/21/2000DE19927571A1 Increasing the levels of flavonoids and phenolic compounds in plants comprises treating the plants with growth-regulating 4-acyl-3,5-dioxo-1-cyclohexanecarboxylic acid derivatives
12/21/2000CA2391364A1 47 human secreted proteins
12/21/2000CA2391361A1 47 human secreted proteins
12/21/2000CA2390946A1 49 human secreted proteins
12/21/2000CA2387696A1 48 human secreted proteins
12/21/2000CA2383048A1 49 human secreted proteins
12/21/2000CA2382769A1 42 human secreted proteins
12/21/2000CA2382748A1 50 human secreted proteins
12/21/2000CA2382743A1 48 human secreted proteins
12/21/2000CA2382735A1 49 human secreted proteins
12/21/2000CA2377320A1 Methods for modulating fxr receptor activity
12/21/2000CA2377153A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000CA2376956A1 Charged compounds facilitate viral transduction of cells
12/21/2000CA2376735A1 Recombinant adenoviruses for the sodium/iodide symporter (nis)
12/21/2000CA2376717A1 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000CA2376467A1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production
12/21/2000CA2376389A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000CA2376296A1 Urea substituted imidazoquinolines
12/21/2000CA2376067A1 Use of paclitaxel and steroid derivatives as aromatase inhibitors for the treatment of cancer
12/21/2000CA2375920A1 Compounds
12/21/2000CA2374909A1 Human intracellular signaling molecules
12/21/2000CA2370316A1 Rhodanine derivatives and their use in inhibiting and imaging amyloids
12/21/2000CA2340375A1 Agent for enhancing accumulation of drugs in tumor tissues
12/20/2000EP1061129A1 Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses
12/20/2000EP1061081A1 7-Oxo-2,3,7,14-tetrahydro-1H-benzo[b]pyrano[3,2-h]acridine carboxylate derivatives, process for their preparation and pharmaceutical compositions containing them
12/20/2000EP1060254A2 Human proteinase molecules
12/20/2000EP1060247A1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
12/20/2000EP1060242A1 Purified populations of stem cells
12/20/2000EP1060193A2 Cd147 binding molecules as therapeutics
12/20/2000EP1060188A1 Cholenic acid amides and pharmaceutical compositions thereof
12/20/2000EP1060182A2 Novel prodrugs for phosphorus-containing compounds
12/20/2000EP1060167A1 Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed et a?/et b?-receptor antagonists
12/20/2000EP1060164A1 Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists
12/20/2000EP1060163A1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
12/20/2000EP1060161A1 Matrix metalloproteinase inhibitors
12/20/2000EP1060160A2 Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs
12/20/2000EP1059944A1 Detector molecule for use in a method for detecting and surgically removing lymphoid tissue involved in tumor progression
12/20/2000EP1059942A2 Pharmaceutical compositions containing cyclodextrins and taxoids
12/20/2000EP1059931A2 Utilization of cd137 in order to promote the proliferation of peripheral monocytes
12/20/2000EP1059929A2 Isolated stromal cells for use in the treatment of diseases of the central nervous system
12/20/2000EP1059913A1 Emulsion preconcentrates containing cyclosporin or a macrolide
12/20/2000EP0938309A4 Methods for in vivo reduction of iron levels and compositions useful therefor
12/20/2000EP0754030B1 Method for stabilizing duocarmycin derivatives
12/20/2000CN1277634A New tissue-specific calpaines, their production and their use
12/20/2000CN1277633A Mutants of thyroid stimulating hormone and methods based thereon
12/20/2000CN1277614A Mammaglobin a secreted mammary-specific breast cancer protein
12/20/2000CN1277613A Poly (ADP-ribose) polymerase ('PARP') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
12/20/2000CN1277605A Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors
12/20/2000CN1277197A Stable crystal salt of 5-methyl tetrahydrofolic acid
12/20/2000CN1277049A Medicine for treating breast tumor and carbuncle
12/20/2000CN1277039A Cancer treating medical composition
12/20/2000CN1277034A Chinese medicine preparation
12/20/2000CN1059705C Composition for introducing nucleic acid complexes into higher eucaryotic cells
12/20/2000CN1059581C Anticancer paste
12/20/2000CN1059580C Sikang yangsheng health-care tablet
12/20/2000CN1059575C Traditional Chinese medicine for treating cancer
12/20/2000CN1059565C Application for treating cancer and its preparing method
12/20/2000CN1059556C Compound cinobufogin
12/19/2000US6162920 Taxane derivatives having a pyridyl substituted C13 side chain, their preparation and their use as anti-tumor agents
12/19/2000US6162822 Bisimide compounds
12/19/2000US6162813 Antagonists of gonadotropin releasing hormone
12/19/2000US6162811 Antitumor agents
12/19/2000US6162808 Compounds
12/19/2000US6162790 Oligopeptides
12/19/2000US6162612 Enzymatic polypeptide; for te detection of enzyme inhibitor which can be used to treat cancer, psoriasis and vascular system defects; anticarcinogenic agents
12/19/2000US6162600 Indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
12/19/2000US6162445 Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof
12/19/2000US6162444 Cosmetic or pharmaceutical compositions
12/19/2000US6162436 Compositions and methods using complexes of heat shock protein 90 and antigenic molecules for the treatment and prevention of neoplastic diseases
12/19/2000US6162427 Treating tumor by administering colony stimulating factor
12/19/2000CA2159787C Dibenzofuran aromatic derivatives; pharmaceutical and cosmetic compositions containing the same
12/19/2000CA2053206C Monoclonal antibodies against melanoma
12/19/2000CA2050291C Combination therapy for the treatment of estrogen sensitive diseases
12/14/2000WO2000075375A1 26 human secreted proteins
12/14/2000WO2000075348A1 Recombinant anti-cd40 antibody and uses thereof
12/14/2000WO2000075347A2 Tet repressor-based transcriptional regulatory proteins
12/14/2000WO2000075339A1 Substrate trapping protein tyrosine phosphatases
12/14/2000WO2000075333A1 Streptavidin expressed gene fusions and methods of use thereof
12/14/2000WO2000075323A1 Tek antagonists
12/14/2000WO2000075319A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000WO2000075318A1 Phospholipid transfer protein
12/14/2000WO2000075317A2 Compositions and methods for the treatment of tumor
12/14/2000WO2000075309A1 Spliceosome protein and its use
12/14/2000WO2000075292A1 Herpes simplex virus expressing foreign genes and method for treating cancers therewith
12/14/2000WO2000075284A1 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use
12/14/2000WO2000075279A2 Nucleotide sequences for gene regulation and methods of use thereof
12/14/2000WO2000075191A2 Apo-2L RECEPTOR AGONIST AND CPT-11 SYNERGISM
12/14/2000WO2000075186A1 Neuromedin b and somatostatin receptor agonists
12/14/2000WO2000075175A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000WO2000075163A1 Angiogenic proteins and uses thereof
1 ... 1862 1863 1864 1865 1866 1867 1868 1869 1870 1871 1872 1873 1874 1875 1876 1877 1878 1879 1880 1881 1882 ... 2211